vs
DIAMOND HILL INVESTMENT GROUP INC（DHIL）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
DIAMOND HILL INVESTMENT GROUP INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.0倍（$36.6M vs $35.5M），DIAMOND HILL INVESTMENT GROUP INC净利率更高（25.3% vs -304.2%，领先329.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -6.6%），DIAMOND HILL INVESTMENT GROUP INC自由现金流更多（$-9.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 0.4%）
钻石棒球控股（DBH）是一家美国体育产权持有与运营集团，在美国和加拿大拥有并运营超过40支小联盟棒球队。该公司由媒体集团奋进集团于2021年成立，目前是投资机构银湖旗下的子公司，专注于北美小联盟棒球产业的运营与发展。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
DHIL vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.6M | $35.5M |
| 净利润 | $9.3M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 16.9% | -304.8% |
| 净利率 | 25.3% | -304.2% |
| 营收同比 | -6.6% | 681.7% |
| 净利润同比 | 25.3% | 39.6% |
| 每股收益（稀释后） | $3.42 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $36.6M | $35.5M | ||
| Q3 25 | $37.4M | $5.2M | ||
| Q2 25 | $36.0M | $19.2M | ||
| Q1 25 | $37.1M | $14.7M | ||
| Q4 24 | $39.1M | $4.5M | ||
| Q3 24 | $39.0M | $26.1M | ||
| Q2 24 | $36.7M | $14.4M | ||
| Q1 24 | $36.3M | $13.8M |
| Q4 25 | $9.3M | $-108.1M | ||
| Q3 25 | $13.6M | $-162.3M | ||
| Q2 25 | $15.6M | $-171.9M | ||
| Q1 25 | $10.4M | $-202.5M | ||
| Q4 24 | $7.4M | $-178.9M | ||
| Q3 24 | $14.6M | $-95.8M | ||
| Q2 24 | $8.1M | $-97.5M | ||
| Q1 24 | $13.0M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 16.9% | -304.8% | ||
| Q3 25 | 26.0% | -3327.6% | ||
| Q2 25 | 21.6% | -916.8% | ||
| Q1 25 | 35.2% | -1297.9% | ||
| Q4 24 | 33.8% | -4042.4% | ||
| Q3 24 | 26.2% | -377.1% | ||
| Q2 24 | 33.1% | -697.4% | ||
| Q1 24 | 22.9% | -698.4% |
| Q4 25 | 25.3% | -304.2% | ||
| Q3 25 | 36.2% | -3135.3% | ||
| Q2 25 | 43.2% | -894.2% | ||
| Q1 25 | 27.9% | -1373.3% | ||
| Q4 24 | 18.9% | -3935.5% | ||
| Q3 24 | 37.5% | -367.5% | ||
| Q2 24 | 22.2% | -676.6% | ||
| Q1 24 | 35.9% | -662.4% |
| Q4 25 | $3.42 | $-0.17 | ||
| Q3 25 | $4.99 | $-0.36 | ||
| Q2 25 | $5.73 | $-0.41 | ||
| Q1 25 | $3.77 | $-0.50 | ||
| Q4 24 | $2.76 | $-0.56 | ||
| Q3 24 | $5.35 | $-0.34 | ||
| Q2 24 | $2.93 | $-0.40 | ||
| Q1 24 | $4.62 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $176.4M | $1.1B |
| 总资产 | $260.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | $41.6M | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $176.4M | $1.1B | ||
| Q3 25 | $180.9M | $1.0B | ||
| Q2 25 | $171.6M | $919.1M | ||
| Q1 25 | $168.6M | $933.9M | ||
| Q4 24 | $162.3M | $1.0B | ||
| Q3 24 | $166.5M | $524.6M | ||
| Q2 24 | $156.5M | $584.4M | ||
| Q1 24 | $158.3M | $401.2M |
| Q4 25 | $260.4M | $1.5B | ||
| Q3 25 | $256.3M | $1.4B | ||
| Q2 25 | $261.0M | $1.3B | ||
| Q1 25 | $224.4M | $1.3B | ||
| Q4 24 | $245.1M | $1.4B | ||
| Q3 24 | $240.8M | $726.5M | ||
| Q2 24 | $213.1M | $775.9M | ||
| Q1 24 | $209.1M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-9.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | -24.8% | -133.1% |
| 资本支出强度资本支出/营收 | 6.7% | 3.5% |
| 现金转化率经营现金流/净利润 | -0.71× | — |
| 过去12个月自由现金流最近4个季度 | $-34.3M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-6.6M | $-46.1M | ||
| Q3 25 | $-7.7M | $-117.4M | ||
| Q2 25 | $-5.0M | $-76.4M | ||
| Q1 25 | $-10.7M | $-132.0M | ||
| Q4 24 | $16.6M | $-115.4M | ||
| Q3 24 | $18.5M | $-59.2M | ||
| Q2 24 | $19.2M | $-82.2M | ||
| Q1 24 | $-12.3M | $-102.3M |
| Q4 25 | $-9.1M | $-47.3M | ||
| Q3 25 | $-8.3M | $-117.6M | ||
| Q2 25 | $-5.7M | $-79.6M | ||
| Q1 25 | $-11.3M | $-133.8M | ||
| Q4 24 | $15.2M | $-116.7M | ||
| Q3 24 | $18.3M | $-63.8M | ||
| Q2 24 | $19.2M | $-83.4M | ||
| Q1 24 | $-12.4M | $-109.0M |
| Q4 25 | -24.8% | -133.1% | ||
| Q3 25 | -22.2% | -2272.5% | ||
| Q2 25 | -15.8% | -413.9% | ||
| Q1 25 | -30.4% | -907.4% | ||
| Q4 24 | 38.9% | -2567.7% | ||
| Q3 24 | 46.8% | -244.6% | ||
| Q2 24 | 52.4% | -578.5% | ||
| Q1 24 | -34.2% | -789.9% |
| Q4 25 | 6.7% | 3.5% | ||
| Q3 25 | 1.6% | 4.7% | ||
| Q2 25 | 2.0% | 16.4% | ||
| Q1 25 | 1.5% | 12.4% | ||
| Q4 24 | 3.5% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 0.0% | 8.2% | ||
| Q1 24 | 0.4% | 48.2% |
| Q4 25 | -0.71× | — | ||
| Q3 25 | -0.57× | — | ||
| Q2 25 | -0.32× | — | ||
| Q1 25 | -1.04× | — | ||
| Q4 24 | 2.25× | — | ||
| Q3 24 | 1.26× | — | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | -0.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHIL
| Proprietary Funds | $26.0M | 71% |
| Separately Managed Accounts | $5.0M | 14% |
| Other Pooled Vehicles | $2.8M | 8% |
| Administration Revenuenetofrelatedexpense | $1.7M | 5% |
| Collective Investment Trusts | $1.4M | 4% |
RXRX
暂无分部数据
